Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAIBE for Patients With Potentially Resectable Locally Advanced Pancreatic Cancer
NCT03523312Phase 2Active, not recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Apr 2018
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in pancreatic cancer (PC), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Proportion of patients who undergo definitive surgery at 2 years. Started Apr 2018; status: active, not recruiting.
02
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT03523312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03523312.